Healthcare Industry News: PENTAX Medical
News Release - May 18, 2016
PENTAX Medical Launches OPTIVISTA EPK-i7010 Video ProcessorGo Beyond Conventional White Light Endoscopy with PENTAX Medical Enhancement Technologies
MONTVALE, N.J., May 18, 2016 -- (Healthcare Sales & Marketing Network) -- PENTAX Medical Corp. (PENTAX Medical), a healthcare industry leader in endoscopic imaging, announced today the launch of the OPTIVISTA EPK-i7010 Video Processor (OPTIVISTA), featuring both digital and optical enhancements. The OPTIVISTA, which will premiere during Digestive Disease Week, offers physicians digital and optical-based electronic chromoendoscopy with new i-SCANTM imaging and OE Optical Enhancement technology (OE). This unique enhancement expands applications to a broader range of clinical needs across detection, identification and confirmation during endoscopy.
OE uses a spectral light filter that transmits band limited red, green, and blue light and is intended to provide the user with an enhanced image of blood vessels, glandular ducts, and the fine structure of the mucosal membrane in higher contrasts than white light. This may provide additional clarity of vascular patterns and confidence to adopt in vivo histology of lesions.
OPTIVISTA is perfectly suited for routine procedures or complex interventions and provides market-leading image quality. Physicians can switch seamlessly in real time between HD+ white light, two OE modes, and three i-SCAN modes to view multiple aspects of tissue structure. The OPTIVISTA can work together with the latest i10 HD+ endoscopes series, MagniView, or optical zoom endoscopes to deliver advanced visualization to support physician requirements for the detection and treatment of GI disease.
Silvia Sanduleanu, MD, PhD, Maastricht University Medical Center, The Netherlands, who was involved in early studies with the OPTIVISTA said, "Contrast enhancement using OE highlights the epithelial mucosal surface pattern and especially the vascular pattern in detail."
In addition to improved diagnosis, OPTIVISTA is a powerful teaching platform. HD TwinMode is useful for teaching appropriate interpretation of image enhanced endoscopy, providing a simultaneous comparison of side-by-side endoscopic images. This enhanced comparison is particularly useful in demonstrating the appropriate characterization of lesions.
Included with the OPTIVISTA is the ability to perform video recording, which allows the capture of HD+ video files onto a USB storage device. Audio recording for video is captured through an external microphone. The intuitive touch screen controls enable simple and efficient operation. For optimum image collection, the OPTIVISTA incorporates freeze scan technology, which automatically selects the sharpest picture for users' records. By integrating the video and audio capture functionality, there is no requirement for additional recording devices or software.
David Woods, Chief Marketing Officer of PENTAX Medical commented, "The OPTIVISTA EPK-i7010 Video Processor is an exciting addition to our product platform and exhibits PENTAX Medical's commitment to continuous innovation and delivering products and services that have enhanced clinical relevance."
About PENTAX Medical
PENTAX Medical is a division of HOYA Group. Its mission is to improve the standard of patient care and quality of healthcare delivery by providing the best endoscopic products and services with a focus on QUALITY, CLINICALLY RELEVANT INNOVATION, and SIMPLICITY. Through leading edge R&D and manufacturing, PENTAX Medical provides endoscopic imaging devices and solutions to the global medical community. Headquartered in Japan, PENTAX Medical has a worldwide focus and presence with R&D, regional sales, service, and in-country facilities around the globe. PENTAX Medical employees represent the diverse countries where we do business, allowing us to provide innovative solutions tailored to meet local needs. For more information, please visit: www.pentaxmedical.com.
Source: PENTAX Medical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.